A composite photocurable bio-ink, its preparation method and application
A one-pot synthesis of methacrylamide gelatin/sodium alginate/hydroxyapatite composite bio-ink solves the problems of insufficient material selection, cell survival rate and mechanical properties of existing bio-inks in 3D printing, and realizes the application of efficient bone repair materials.
Patent Information
- Application Number
- CN202311429078.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-31
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-10-31
AI Technical Summary
Existing bio-inks suffer from limitations in material selection, low cell survival rates, and insufficient mechanical properties in 3D printing, making it difficult to meet the needs of bone tissue engineering.
A novel synthetic method was used to synthesize a composite bio-ink of methacrylamide gelatin/sodium alginate/hydroxyapatite. Composite hydrogel particles were prepared by a one-pot method, and bone marrow mesenchymal stem cells, photoinitiators, and light absorbers were added to achieve self-mineralization and promote osteogenic differentiation.
It improves cell survival rate and osteogenic effect, enhances the mechanical properties and stability of 3D printed structures, is suitable for bone repair materials, and promotes the regeneration of bone defects in bone tissue engineering.
Smart Images

Figure CN117414471B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the fields of biomaterials and tissue engineering, and particularly to a composite bio-ink containing methacrylated gelatin / sodium methacrylated alginate or methacrylated gelatin / sodium methacrylated alginate / hydroxyapatite for bone repair, and its preparation method and application. Background Technology
[0002] 3D bioprinting technology, as a disruptive innovation in the field of biomedical engineering, has significant advantages in the construction of complex tissues and organs, especially in bone tissue engineering. Among the many 3D printing technologies, Digital Light Processing (DLP) is a precise photopolymerization technology for 3D printing. It uses digital light projection to illuminate photopolymerized layers onto a liquid photopolymerized bioink, thereby achieving precise 3D printing. Compared with traditional layer-by-layer deposition methods, DLP technology has higher speed and resolution; however, the availability of photopolymerized inks is currently limited, and there is still a need to optimize and develop new photopolymerized inks to meet the specific requirements of bioinks.
[0003] Over the past few years, researchers have extensively investigated the development of various bio-inks to support cell survival and tissue construction during the 3D printing process. Despite the enormous potential of 3D bioprinting technology in biomedical engineering, several key issues and challenges remain. These include:
[0004] (1) Material limitations: Existing bio-inks have certain limitations in terms of selection and availability, which leads to challenges in printing diverse structures. Most existing technologies adopt the method of simply mixing GelMA-based photocurable bio-inks with other materials, which may result in excessively high viscosity, difficulty in controlling the degree of photocuring, or difficulty in uniform distribution during the printing process; (2) Low cell survival rate and lack of osteogenic function: Cell survival rate is a key factor in 3D bioprinting. Currently, it is necessary to improve the composition of bio-inks to improve cell survival and related functions of promoting osteogenic differentiation of stem cells; (3) Insufficient mechanical properties: Some bio-inks have relatively poor structural mechanical properties after photocuring, which limits their application in the fields of biomedicine and bioengineering, especially for applications that require high strength and high stability.
[0005] This invention overcomes material limitations, differing from traditional methods that involve separately synthesizing bio-inks and then simply mixing them for printing. A novel one-pot synthesis method was employed to successfully synthesize methacrylamide-gelatin / sodium alginate / hydroxyapatite, and this novel bio-ink was used for long-term cell culture. Results demonstrated that it can achieve self-mineralization in vitro, significantly improving the osteogenic effect and mechanical properties of stem cells. This invention addresses the shortcomings of existing bio-inks, driving innovation in DLP printing for bone tissue repair. Summary of the Invention
[0006] To address the problems existing in the prior art, the purpose of this invention is to provide a method for preparing and applying a composite photocurable bio-ink and a DLP printing scaffold, thereby broadening the diversity and usability of photocurable bioprinting inks. The composite bio-ink is synthesized using a novel one-pot method, which is simple and efficient, avoiding printing problems caused by simple mixing. The printed material also possesses unique advantages, such as good bioactivity, supporting long-term cell culture and differentiation, and promoting self-mineralization and osteogenic formation. It is expected to significantly improve the mechanical strength and stability of 3D printed structures and can be used as a bone repair material in bone tissue engineering.
[0007] The objective of this invention can be specifically achieved through the following technical solutions:
[0008] In a first aspect, the present invention provides a composite photocurable bio-ink that can be used for digital light processing 3D bioprinting. The composite bio-ink comprises methacrylamide gelatin (GelMA) / methacrylamide sodium alginate (AlgMA) composite hydrogel particles (Gel / AlgMA) or methacrylamide gelatin (GelMA) / methacrylamide sodium alginate (AlgMA) / hydroxyapatite (HAP) composite hydrogel particles (Gel / Alg / HAP), and has the characteristics of good biocompatibility, good photocurability, self-mineralization, and promotion of osteogenic differentiation.
[0009] In one or more embodiments of the present invention, the concentration of composite hydrogel particles Gel / AlgMA or Gel / Alg / HAP in the composite bio-ink is 5wt% to 15wt%.
[0010] In one or more embodiments of the present invention, the composite bio-ink further comprises bone marrow mesenchymal stem cells, a photoinitiator, and a light absorber.
[0011] In one or more embodiments of the present invention, the concentration of the bone marrow mesenchymal stem cells is 5 x 10⁻⁶. 5 ~5x10 6 cells / mL; the photoinitiator is lithium phenyl (2,4,6-trimethylbenzoyl)phosphate, and the concentration of the photoinitiator is 0.05-0.5 wt%; the light absorber is EFL-UVAW-001, and the concentration of the light absorber is 0.01-0.1 wt%.
[0012] In one or more embodiments of the present invention, the preparation method of the methacrylamide gelatin / sodium methacrylamide alginate composite hydrogel particles (Gel / AlgMA) includes the following steps:
[0013] S1. Dissolve gelatin and sodium alginate in their respective deionized water solutions, stirring thoroughly until dissolved;
[0014] S2. Then mix the two solutions, add the methacrylamide MA dropwise, stir thoroughly, and adjust the pH to 8-10.
[0015] S3. The reaction is carried out at 50°C for 3 hours. Finally, a large volume of deionized water is added to terminate the reaction. Then, the mixture is dialyzed for one week and then lyophilized.
[0016] In one or more embodiments of the present invention, the mass ratio of gelatin to sodium alginate is 20:1 to 5:1.
[0017] In one or more embodiments of the present invention, the mass-to-volume ratio of the gelatin to deionized water is 1:5 to 1:20.
[0018] In one or more embodiments of the present invention, the mass-to-volume ratio of sodium alginate to deionized water is 1:50 to 1:200.
[0019] In one or more embodiments of the present invention, the ratio of the methacrylamide MA to gelatin is 1:10 to 1:2.
[0020] In one or more embodiments of the present invention, the concentration of the methacrylated gelatin / methacrylated sodium alginate is 2 wt% to 2.5 wt%.
[0021] In one or more embodiments of the present invention, the preparation method of the methacrylamide gelatin / methacrylamide sodium alginate composite hydrogel particles (Gel / AlgMA) is as follows:
[0022] (1) Dissolve 10 g of gelatin and 0.5 g of sodium alginate in 50 ml of deionized water to prepare a 20 wt% solution and stir well.
[0023] (2) Mix the two solutions, stir thoroughly, add 4 ml of methacrylic anhydride dropwise, and adjust the initial pH to 8-10 at the same time.
[0024] (3) The reaction was carried out at 50°C for 3 hours, and warm water was added to terminate the reaction. The resulting mixture was dialyzed using a dialysis bag with a molecular weight of 13,000 for 7 days at 37°C. After dialysis, it was freeze-dried.
[0025] In one or more embodiments of the present invention, the preparation method of the methacrylamide gelatin / sodium methacrylamide alginate / hydroxyapatite composite hydrogel particles (Gel / Alg / HAP) includes the following steps:
[0026] S1. Dissolve gelatin and sodium alginate in their respective deionized water solutions, stirring thoroughly until dissolved;
[0027] S2. Then slowly add the calcium chloride and disodium hydrogen phosphate solution dropwise to the sodium alginate solution, adjust the pH to 8-10, and stir thoroughly overnight.
[0028] S3. Mix gelatin with sodium alginate solution containing calcium chloride and disodium hydrogen phosphate, add methacrylamide MA dropwise, stir thoroughly and adjust the pH to 8-10;
[0029] S4. The reaction was carried out at 50°C for 3 hours. Finally, a large volume of deionized water was added to terminate the reaction. Then, the mixture was dialyzed for one week and lyophilized for later use.
[0030] In one or more embodiments of the present invention, the mass ratio of gelatin to sodium alginate in step S1 is 20:1 to 5:1.
[0031] In one or more embodiments of the present invention, the mass-to-volume ratio of gelatin to deionized water in step S1 is 1:5 to 1:20.
[0032] In one or more embodiments of the present invention, the mass-to-volume ratio of sodium alginate to deionized water in step S1 is 1:50 to 1:200.
[0033] In one or more embodiments of the present invention, the ratio of the methacrylamide MA to gelatin in step S1 is 1:10 to 1:2.
[0034] In one or more embodiments of the present invention, the concentration of the calcium chloride and disodium hydrogen phosphate solution in step S2 is 0.1 wt% to 5 wt%.
[0035] In one or more embodiments of the present invention, the feeding ratio of calcium chloride and disodium hydrogen phosphate solution to sodium alginate solution in step S2 is 1:10 to 1:25.
[0036] In one or more embodiments of the present invention, the concentration of the methacrylated gelatin / methacrylated sodium alginate is 2 wt% to 2.5 wt%.
[0037] In one or more embodiments of the present invention, the preparation method of the composite hydrogel particles Gel / Alg / HAP is as follows:
[0038] (1) Take 10 grams of gelatin, add 50 ml of deionized water, and stir at 50°C to obtain a 20 wt% solution;
[0039] (2) In another container, take 0.5 g of sodium alginate, add 42 mL of deionized water, and then slowly add 4 mL of CaCl2 and NaH2PO4 at a rate of 50 μL per minute. Adjust the pH to 8-10 and stir vigorously. Then let the reaction stand overnight.
[0040] (3) Combine the two solutions and mix them thoroughly. Slowly add 4 mL of MA while adjusting the initial pH to 8-10;
[0041] (4) The reaction was carried out at 50°C for 3 hours. Finally, 300 ml of warm water was added to terminate the reaction and kept for 30 minutes.
[0042] (5) Dialyze the resulting mixture using a dialysis bag with a molecular weight of 13,000 at 37°C for 7 days to remove any unreacted small molecules. After dialysis, freeze dry the mixture.
[0043] A second aspect of the present invention provides a composite biological scaffold, which is prepared by 3D printing from the aforementioned composite biological ink containing composite hydrogel particles Gel / AlgMA or Gel / Alg / HAP.
[0044] A third aspect of this invention provides a method for preparing the composite biological scaffold, specifically comprising the following steps:
[0045] S1. Create a 3D model using 3D Studio Max software;
[0046] S2. Place the bio-ink into the material tank, set the printing parameters, and print;
[0047] S3. After printing, quickly place the printed cell scaffold into the culture medium.
[0048] In one or more embodiments of the present invention, the printing parameters in step S2 are: light intensity set to 5-20 mW / cm². -2 The exposure time is set to 8–20 seconds, the base layer number is 0–5 layers, the bottom layer exposure time is set to 10–22 seconds, the layer height is set to 20–100 micrometers, and the printing temperature is 26–37℃.
[0049] The fourth aspect of this invention provides the composite biological scaffold for use in bone tissue repair and regenerative medicine.
[0050] Compared with the prior art, the present invention has the following technical effects:
[0051] Firstly, the composite bio-ink of this invention uses biocompatible materials as raw materials, which have advantages such as high mechanical properties and photocurability; and the components of the bio-ink can be customized to meet the personalized requirements of specific cell or tissue construction.
[0052] Secondly, the composite bio-ink of this invention can achieve cell encapsulation bioprinting, enabling stem cells to grow stably and structurally in a three-dimensional environment for a long time, while achieving mineralization and osteogenic differentiation effects.
[0053] Third, the composite scaffold of the present invention can also be used to construct other artificial organ models to achieve bone defect regeneration and repair. Attached Figure Description
[0054] Figure 1 A schematic diagram of the preparation method of composite bio-ink for bone tissue engineering.
[0055] Figure 2 NMR and IR spectra of the composite hydrogel particles prepared in Example 1.
[0056] Figure 3 Rheological and mechanical property data of the composite bio-ink prepared in Example 2.
[0057] Figure 4 Photocurable printing performance data of the composite bio-ink prepared in Example 3.
[0058] Figure 5 Cell viability and mortality staining images of the composite bio-ink prepared in Example 4 on days 1, 4, and 7.
[0059] Figure 6 The mineralization results of the composite bio-ink prepared in Example 2 after 20 and 40 days of in vitro culture.
[0060] Figure 7 MicroCT results of rat skull defects using the composite biological scaffold prepared in Example 5.
[0061] Figure 8 Tissue staining results of rat skull defects using the composite biological scaffold prepared in Example 5. Detailed Implementation
[0062] The present invention will be described in detail below with reference to specific embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but do not limit the present invention in any way. It should be noted that those skilled in the art can make several modifications and improvements without departing from the concept of the present invention, and these all fall within the protection scope of the present invention.
[0063] The instruments and reagents used in the examples and their sources are as follows:
[0064] Gelatin (G88891B, C) 102 H 151 O 39 N 31 All reagents, chemicals, assay kits, and solvents were purchased from General Reagent; sodium alginate (product number: 180947, C6H7NaO6) was purchased from Sigma-Aldrich, USA; lithium phenyl-2,4,6-trimethylbenzoylphosphonate (LAP) and blue light source were purchased from Suzhou Institute of Intelligent Manufacturing. Dulbecco phosphate-buffered saline (DPBS), fetal bovine serum (FBS), DMEM, and penicillin were purchased from Gibco Invitrogen. Eight-week-old SD rats and C57BL / 6 mice were purchased from Changzhou Cavens Laboratory Animal Co., Ltd. All other reagents, chemicals, assay kits, and solvents were purchased from commercial suppliers.
[0065] Example 1: Preparation and Characterization of Composite Hydrogels
[0066] 1.1 Preparation of GelMA hydrogel
[0067] (1) Dissolve 10 grams of gelatin in 100 ml of deionized water and stir evenly at 50°C to prepare a 10 wt% solution;
[0068] (2) Add 4 mL of methacrylic anhydride dropwise at a rate of 0.5 mL / min;
[0069] (3) The reaction was carried out at 50°C for 3 hours, and 300 ml of warm water was added to terminate the reaction for 30 minutes. The resulting mixture was dialyzed using a dialysis bag with a molecular weight of 13000 and dialyzed with distilled water at 37°C for 7 days.
[0070] (4) The dialyzed hydrogel was placed in liquid nitrogen and frozen into a solid for 30 minutes. Then it was transferred to a freeze dryer and freeze-dried at -80°C and 0 Pa for 7 days to remove moisture. The obtained sample was methacrylated gelatin.
[0071] 1.2 Preparation of composite hydrogel Gel / AlgMA
[0072] (1) Dissolve 10 g of gelatin and 0.5 g of sodium alginate in 50 ml of deionized water and stir evenly at 50 °C to prepare 20 wt% solution and 1 wt% solution respectively.
[0073] (2) Mix the two solutions and stir thoroughly. Add 4 ml of methacrylic anhydride dropwise at a rate of 0.5 ml / min. At the same time, adjust the initial pH value to 8-10 with 2 M NaOH solution.
[0074] (3) The reaction was carried out at 50°C for 3 hours, and 300 ml of warm deionized water was added to terminate the reaction for 30 minutes. The resulting mixture was dialyzed using a dialysis bag with a molecular weight of 13000 and dialyzed with distilled water at 37°C for 7 days.
[0075] (4) The dialyzed hydrogel was placed in liquid nitrogen and frozen into a solid for 30 minutes. Then it was transferred to a freeze dryer and freeze-dried at -80°C and 0 Pa for 7 days to fully remove moisture. The obtained sample was a methacrylated gelatin / methacrylated sodium alginate composite hydrogel.
[0076] 1.3 Preparation of composite hydrogel Gel / Alg / HAP
[0077] (1) Add 10g of gelatin to 50ml of deionized water to obtain a 20wt% solution at 50℃.
[0078] (2) Then add 0.5g sodium alginate to 42ml deionized water, and then add 4ml of 1M CaCl2 and 4ml of 0.6M NaH2PO4 at a rate of 50μL / min. Adjust the pH to 8-10 with 2M NaOH, stir the solution and let it react overnight.
[0079] (3) Mix the two solutions from steps (1) and (2) thoroughly, add 4 ml of methacrylic anhydride at a rate of 0.5 ml / min, and finally adjust the initial pH to 8-10 with 2 M NaOH.
[0080] (3) The reaction was carried out at 50°C for 3 hours, and then 300 ml of warm deionized water was added to terminate the reaction for 30 minutes. After the reaction was completed, the hydrogel solution was transferred to a dialysis bag and dialyzed with distilled water at 37°C for 7 days. The molecular weight specification of the dialysis bag was 13000.
[0081] (4) The dialyzed hydrogel was placed in liquid nitrogen and frozen into a solid for 30 minutes. Then it was transferred to a freeze dryer and freeze-dried at -80°C and 0 Pa for 7 days to remove moisture. The obtained sample was a methacrylated gelatin / methacrylated sodium alginate / hydroxyapatite composite hydrogel (Gel / Alg / HAP).
[0082] 1.4 Chemical structural characterization of Gel / AlgMA and Gel / Alg / HAP
[0083] The chemical structures of GelMA, Gel / AlgMA, and Gel / Alg / HAP were verified by nuclear magnetic resonance (NMR) and Fourier transform infrared (FTIR) spectroscopy, such as... Figure 2 As shown. 1 HNMR results showed new characteristic peaks (referred to as peak "a+b", representing the acrylic proton, =CH2) at approximately 5.3 and 5.5 ppm, compared to gelatin, indicating the introduction of a methacrylamide group. FTIR analysis of AlgMA at 1735 cm⁻¹... -1 The characteristic peaks of the C double bond and O group at the position confirmed the formation of a link between methacrylate (MA) and sodium alginate. NMR analysis showed the introduction of the methacryloyl group, while FTIR analysis further confirmed the occurrence of chemical modification.
[0084] Example 2: Preparation and Characterization of Composite Bio-ink
[0085] 2.1 Preparation of bone marrow mesenchymal stem cell (BMSCs) suspension
[0086] Four-week-old SPF-grade SD rats were euthanized by cervical dislocation and soaked in 75% ethanol. The outer and inner skin of the legs were then cut open, and the bilateral femurs and tibias were aseptically removed and soaked in sterile PBS solution containing antibiotics. The muscles and connective tissue surrounding the femurs and tibias were removed, and the bones were washed three times with PBS solution containing antibiotics. The ends of the femurs and tibias were cut off with ophthalmic scissors to expose the medullary cavity. The medullary cavity was repeatedly flushed with complete culture medium using a syringe until the bone hairs turned white. Bone marrow fluid was collected, centrifuged, and then inoculated into culture dishes with appropriate culture medium (containing 20% serum) and cultured in a cell culture incubator at 37°C, 5% CO2, and saturated humidity. After 24–48 hours, the suspension was removed, and the medium was changed every 3 days thereafter. The obtained cells were bone marrow mesenchymal stem cells (BMSCs), which were passaged to 3–5 times for future use.
[0087] BMSCs were digested with trypsin, centrifuged to obtain cell pellet, and a small amount of culture medium was added for cell counting.
[0088] 2.2 Preparation of Methacrylamide Gelatin Bio-ink / BMSCs
[0089] (1) First, the methacrylamide gelatin granules were taken out and ground on a 100-mesh (0.15 mm) sieve. The obtained powder was sterilized by ultraviolet light and dissolved in sterile DPBS to prepare a 10 wt% sterile solution.
[0090] (2) Add the prepared BMSCs suspension to the sterile solution of methacrylamide gelatin hydrogel and mix thoroughly to prepare a cell concentration of 1x10⁻⁶. 6 ~2x10 6 A hydrogel solution with cells / mL and a concentration of 10 wt% methacrylated gelatin.
[0091] (3) Add sterile photoinitiator lithium phenyl (2,4,6-trimethylbenzoyl)phosphate (LAP) and light absorber (EFL-UVAW-001) to the above hydrogel solution to prepare a solution with LAP concentration of 0.25% and light absorber concentration of 0.05%. The obtained solution is methacrylamide gelatin bio-ink.
[0092] 2.3 Preparation of Methacrylamide Gelatin / Methacrylamide Sodium Alginate / BMSCs Composite Bio-ink
[0093] (1) First, the methacrylated gelatin / methacrylated sodium alginate composite hydrogel particles were taken out and ground on a 100-mesh (0.15 mm) sieve. The obtained powder was sterilized by ultraviolet light and dissolved in sterile DPBS to prepare a 10 wt% sterile solution.
[0094] (2) Add the prepared BMSCs suspension to a sterile solution of methacrylated gelatin / methacrylated sodium alginate composite hydrogel, mix thoroughly to prepare a cell concentration of 1x10⁻⁶. 6 ~2x10 6 A hydrogel solution with a concentration of 10 wt% for the methacrylated gelatin / methacrylated sodium alginate complex (cells / mL).
[0095] (3) Add sterile photoinitiator lithium phenyl (2,4,6-trimethylbenzoyl)phosphate (LAP) and light absorber (EFL-UVAW-001) to the above hydrogel solution to prepare a solution with LAP concentration of 0.25% and light absorber concentration of 0.05%. The obtained solution is a methacrylamide gelatin / methacrylamide sodium alginate composite bio-ink.
[0096] 2.4 Preparation of Methacrylamide Gelatin / Methacrylamide Sodium Alginate / Hydroxyapatite / BMSCs Composite Bio-ink
[0097] (1) First, the methacrylated gelatin / methacrylated sodium alginate / hydroxyapatite composite hydrogel particles were taken out and ground on a 100-mesh (0.15 mm) sieve. The obtained powder was sterilized by ultraviolet light and dissolved in sterile DPBS to prepare a 10 wt% sterile solution.
[0098] (2) Add the prepared BMSCs suspension to a sterile solution of methacrylated gelatin / methacrylated sodium alginate / hydroxyapatite composite hydrogel, mix thoroughly to prepare a cell concentration of 1x10⁻⁶. 6 ~2x10 6A hydrogel solution with a concentration of 10 wt% for the methacrylated gelatin / methacrylated sodium alginate / hydroxyapatite complex (cells / mL).
[0099] (3) Add sterile photoinitiator lithium phenyl (2,4,6-trimethylbenzoyl)phosphate (LAP) and light absorber (EFL-UVAW-001) to the above hydrogel solution to prepare a solution with LAP concentration of 0.25% and light absorber concentration of 0.05%. The obtained solution is a composite bio-ink of methacrylated gelatin / methacrylated sodium alginate / hydroxyapatite.
[0100] 2.5 Performance Testing of Composite Bio-ink
[0101] (1) The rheological and mechanical properties of GelMA bio-ink, Gel / AlgMA composite bio-ink and Gel / Alg / HAP composite bio-ink were tested.
[0102] The rheological properties of the bio-ink were evaluated by examining its shear thinning characteristics and viscosity using a rheometer from TA Instruments (USA). Initially, temperature scans were performed in oscillating mode to obtain temperature-dependent storage modulus (G') and loss modulus (G"). The temperature was increased from 0°C to 40°C while maintaining the angular frequency at 10 rad / s. -1 The shear stress was maintained at 5%. Subsequently, at 10 rad / s -1 Shear stress tests were performed at a constant angular frequency of 20°C (oscillation mode) to measure G' and G".
[0103] The mechanical properties of the bio-ink were evaluated using a 1000N electronic universal testing machine (WDW-1, Shanghai Songdun Instrument Manufacturing Co., Ltd., China). The bio-ink was 3D printed into cylinders with a diameter of 7 mm and a height of 8 mm using a DLP printer. The samples were freeze-dried prior to measurement. Compression tests were performed at a rate of 2 mm / min, stopping when the strain-stress curve reached its fracture point. To calculate the compressive Young's modulus, the slope of the compressive strain-stress curve within the linear region (2–4% strain) was determined. This test protocol was applied to six parallel samples.
[0104] Test results are as follows Figure 3 As shown, GelMA, Gel / AlgMA, and Gel / Alg / HAP bio-inks are suitable for DLP printing technology and exhibit superior shear-dilution properties. Mechanical property testing reveals that the Gel / Alg / HAP bio-ink has a higher Young's modulus, making it suitable for bone tissue engineering.
[0105] GelMA, Gel / AlgMA, and Gel / Alg / HAP exhibited gel-like behavior at temperatures below 20°C, with a storage modulus (G') higher than the loss modulus (G"). As the temperature increased, the bio-inks transitioned to a liquid state, and G' became less than G", indicating the thermosensitivity of the gel. This transition is attributed to physical cross-linking, which is reversible in nature. Furthermore, the bio-inks were liquid at room temperature before UV irradiation. However, under UV irradiation, they transformed into hydrogels that could not flow freely from the bottom of the container, clearly demonstrating the occurrence of irreversible chemical cross-linking induced by UV irradiation. The frequency-dependent viscoelastic behavior of the bio-inks was also evaluated. The storage modulus (G') of all groups was higher than the loss modulus (G"), indicating that the synthesized bio-inks formed a relatively stable gel after UV irradiation, suitable for digital light processing (DLP) printing. Figure 3 (B, C). Notably, the HAP group exhibited the highest energy storage modulus, approximately 5 × 10⁻⁶. 3 Pa, while the GelMA group exhibited the lowest storage modulus, at approximately 10 Pa. 2 Pa( Figure 3 D). Furthermore, all bio-inks exhibited shear-thinning behavior, indicating a decrease in viscosity under shear stress. Notably, the Gel / Alg / HAP group displayed higher viscosity and excellent shear-thinning behavior, making it suitable for both DLP and extrusion-based 3D printing, as it can be easily extruded from the printer nozzle. Figure 3 E). Figure 3 G shows the representative stress-strain curves of the dried bio-ink. Notably, the HAP group exhibits a larger fracture strain compared to pure GelMA. The Young's moduli of GelMA, Gel / AlgMA, and Gel / Alg / HAP are 7.8 ± 1.56 MPa, 8.8 ± 1.23 MPa, and 19.4 ± 1.98 MPa, respectively. Figure 3 H). Clearly, the Young's modulus of the Gel / Alg / HAP group showed a significant increase of approximately 220%, highlighting their suitability for bone scaffold applications.
[0106] (2) Mineralization results of GelMA bio-ink, Gel / AlgMA composite bio-ink, and Gel / Alg / HAP composite bio-ink after 20 and 40 days of in vitro culture, such as Figure 6 As shown.
[0107] To investigate scaffold mineralization in vitro, three groups of bio-ink materials were dissolved and loaded with BMSCs to print porous cylinders with a diameter of 5 mm and a thickness of 2 mm. The scaffolds were retrieved after 20 and 40 days of in vitro culture, and macroscopic images and micro-CT scans were performed to assess mineralization in the microenvironment of the scaffolds, which is far from the bone.
[0108] During the 40-day culture period, the in vitro mineral formation and maturation of the bioprinted scaffold were studied using Micro-CT monitoring. Figure 6 Micro-CT images depicted mineralization in the GelMA, Gel / AlgMA, and Gel / Alg / HAP groups at 20 and 40 days. At 40 days, the GelMA and Gel / AlgMA groups showed almost no mineralization, while the Gel / Alg / HAP group exhibited significant mineralization. Therefore, the Gel / Alg / HAP bioprinted scaffolds cultured in vitro for 40 days were classified as bone organoids. Interestingly, in the first 20 days, mineralization primarily occurred on the exterior of the scaffold. However, after 20 days, mineralization also extended to the interior of the scaffold. When viewed from the side, the mineralized tissue showed more uniform growth along the scaffold surface than within the scaffold. Conversely, the other two groups did not exhibit complete scaffold structures over time. From day 20 to day 40, only a few mineralization points were observed in the GelMA and Gel / AlgMA groups, indicating that the self-mineralization process in these groups mainly occurred after day 20. We also quantified the changes in total mineral volume and organic mineral density (OMD) over time. On day 20, the total mineral volume of the Gel / Alg / HAP group was significantly higher than that of the other groups, while there was no significant difference between GelMA and Gel / AlgMA. OMD increased from day 20 to day 40, indicating that mineral maturation occurred over time. Gel / Alg / HAP exhibited the highest OMD value on day 40, significantly higher than both GelMA and Gel / AlgMA. Our results suggest that the addition of HAP enhances mineral maturation produced by BMSCs, thereby forming a scaffold for homogeneous mineralization. Over time, the low-density volume decreased and the high-density volume increased in all groups, implying maturation of mineral content and increased hardness.
[0109] Example 3: Fabrication and Performance Testing of Composite Bioscaffolds
[0110] 3.1 Preparation of composite biological scaffolds
[0111] (1) Use 3D Studio Max software (Autodesk, USA) to create a 3D model. Make a cylinder with a diameter of 7mm and a thickness of 2mm. The cylinder has 21 square spaces in the middle. See attached diagram for details. Figure 4 A.
[0112] (2) 3D bioprinting experiments were conducted using a digital light projection (DLP) printer (EFL-BP-8601Pro, China). Before printing, the machine underwent UV sterilization. GelMA bio-ink, Gel / AlgMA composite bio-ink, and methacryloyl gelatin / sodium alginate / hydroxyapatite composite bio-ink (Gel / Alg / HAP) were added respectively. The printing parameters were set as follows: light intensity 14 mW cm⁻¹ -2 The exposure time was 12 seconds, with two substrate layers, each exposed for 14 seconds, resulting in a penetration depth of 50 μm. During the printing process, the temperature of both the platform and the storage tank was controlled at 37°C. The resulting scaffold was a composite biological scaffold for bone tissue engineering.
[0113] (3) The support was then placed in an incubator at 37°C and 5% CO2 and implanted subcutaneously into nude mice for culture.
[0114] 3.2 Mechanical property testing of composite bioscaffolds and printability testing of composite bioinks
[0115] The mechanical properties of the bio-scaffold and the printability of the composite bio-ink were tested. Their mechanical properties and printability are shown in the attached figure. Figure 4 As shown, the bracket has excellent mechanical properties and good printability.
[0116] Unlike extrusion printing, DLP bioprinting requires bio-inks with excellent uniformity and good flowability. Based on the data mentioned earlier, the synthesized bio-inks appear well-suited for subsequent DLP printing applications. GelMA and Gel / AlgMA bio-inks could be successfully printed into the desired shapes at a concentration of 5%. However, the printability of these bio-inks significantly improved when the concentration increased to 10%. A concentration of 10% was also considered suitable for printing Gel / Alg / HAP bio-inks, ensuring the successful fabrication of the desired structures. By calculating the Pr value (a parameter representing pore interconnectivity) and diffusion rate, all bio-inks were determined to exhibit excellent printability, with no significant differences observed. Figure 4 (C, D). Subsequently, we conducted printing accuracy tests using various shape models. The results showed that all bio-inks achieved a printing accuracy of at least 20 μm. Detailed observation of the printed models under a stereo microscope revealed that structures such as ears and microneedles were clearly defined and matched the intended design very well. This demonstrates the high-resolution printing capability of the synthetic bio-inks. Figure 4 E).
[0117] Example 4: Biocompatibility Test of Composite Bioscaffold
[0118] The biocompatibility of Example 1 was tested, and the results are shown in the appendix. Figure 5As shown, the composite scaffold exhibits good biocompatibility, allowing cells to stretch, grow, and differentiate well within the scaffold's three-dimensional structure.
[0119] To assess the viability of BMSCs on the scaffold, a live / dead staining kit (Calcein / PI Viability / Cytotoxicity Assay Kit, Beyotime, China) was used at 1, 4, and 7 days post-seeding. The staining procedure involved incubating the samples in an assay solution containing 2 μM calcein AM and 4 μM propidium iodide (PI) at 37°C for 15 minutes. Live BMSCs were identified by the green fluorescence of calcein AM, while dead cells were labeled by the red fluorescence of PI. Fluorescence microscopy images were captured to observe and assess cell viability at specified time intervals.
[0120] To quantify BMSC proliferation on scaffolds, the CCK-8 assay was performed at days 1, 4, and 7 post-seeding using the Cell Counting Kit-8 (CCK-8, Beyotime, China). The culture medium was replaced with fresh medium, and the cells were subsequently incubated at 37°C for 1 hour in the presence of 10% CCK-8 solution. After incubation, the optical density (OD) was measured at 450 nm using a multi-functional microplate reader (BioTek, USA).
[0121] To evaluate the biocompatibility of the 3D-printed scaffold, we seeded bone marrow mesenchymal stem cells (BMSCs) onto the scaffold surface. Live / death analysis showed that cell viability was high and the live / death ratio was similar in all groups during the 7-day culture period, highlighting the good biocompatibility of our bio-ink. Figure 5 A). Initially, the cells were evenly distributed in the bioink, appearing as scattered dots. However, over time, we observed significant migration of BMSCs to the scaffold surface, where they gradually proliferated and extended, forming a complex 3D cell network. Furthermore, CCK-8 assay results indicated that the presence of the HAP group was particularly beneficial to MSCs on day 7. Figure 5 B). These findings highlight the enormous potential of our scaffold in various tissue engineering applications.
[0122] Example 5: Testing the in vivo healing-promoting ability of the composite biological scaffold
[0123] Appendix Figure 7 , Figure 8 The images show the in vivo application of the composite scaffolds prepared in Example 3 and the control group for treating skull defects in rats. The Gel / Alg / HAP composite scaffolds can better promote the healing of bone defects, and tissue staining shows that they have a better ability to promote bone differentiation.
[0124] To evaluate the osteogenic potential of the printed scaffolds, we used a rat skull defect model and implanted various scaffolds for 4 and 8 weeks. Figure 7 Bone regeneration performance was assessed using Micro-CT, histological staining, and immunofluorescence staining. Figure 7 As shown, micro-CT scans at weeks 4 and 8 revealed new bone formation. Notably, the Gel / Alg / HAP group exhibited the most significant new bone coverage, superior to the GelMA and Gel / AlgMA groups. Eight weeks after implantation, the defect area significantly decreased, with newly formed bone covering a large proportion of the bone defect in each group. Coronal views supported these findings. Furthermore, bone mineral density (BMD) and bone volume percentage (BV / TV) analyses indicated increased new bone formation in the defect area during the implantation period. Figure 7 (D, E). Compared with the HAP-free scaffold, the HAP-hybrid scaffold resulted in greater new bone formation. The BV / TV in the Gel / Alg / HAP group reached 69.01±6.90% at 8 weeks, significantly higher than that in the GelMA group (27.65±2.12%) and the Gel / AlgMA group (26.98±3.32%), indicating that the presence of HAP promoted a synergistic effect on bone formation in vivo.
[0125] In addition, decalcified histological sections were subjected to chemical staining (HE, Masson) and immunohistochemical analysis, with a focus on bone formation markers (OPN, Runx2) and angiogenesis-related proteins (VEGF) to assess the regenerative process at the cellular and molecular levels. Figure 8 HE staining results were consistent with radiological observations, showing prominent unhealed fracture lines in the GelMA and Gel / AlgMA groups at 8 weeks post-surgery. Conversely, the Gel / Alg / HAP group showed no prominent fracture lines, indicating successful bone regeneration and reconstruction. Crucially, the Gel / Alg / HAP group exhibited higher levels of newly synthesized collagen tissue and higher concentrations of osteoblasts at the fracture site. The Gel / Alg / HAP group showed the highest collagen deposition in Masson staining, characterized by dense and organized collagen fibers very similar to normal bone tissue. In contrast, the GelMA and Gel / AlgMA groups showed callus-like tissue formation. Furthermore, the Gel / Alg / HAP group showed the highest expression levels of OPN, RunX2, and VEGF. Our histological results confirm that Gel / Alg / HAP synergistically enhances osteogenesis in vivo, positioning the Gel / Alg / HAP printed scaffold as a highly promising candidate for bone regeneration.
Claims
1. A composite bio-ink for digital light processing 3D bioprinting, characterized in that, The bio-ink comprises methacrylated gelatin / methacrylated sodium alginate composite hydrogel particles Gel / AlgMA, or methacrylated gelatin / methacrylated sodium alginate / hydroxyapatite composite hydrogel particles Gel / Alg / HAP, wherein the concentration of the composite hydrogel particles Gel / AlgMA or Gel / Alg / HAP is 5wt% to 15wt%. The preparation method of the methacrylamide gelatin / methacrylamide sodium alginate composite hydrogel particles (Gel / AlgMA) includes the following steps: Dissolve gelatin and sodium alginate in their respective deionized water solutions, stirring thoroughly until dissolved. Then mix the two solutions, add the methacrylating agent MA dropwise, stir thoroughly, and adjust the pH to 8-10; The reaction was carried out at 50°C for 3 hours. Finally, a large volume of deionized water was added to terminate the reaction. Then, the mixture was dialyzed for one week and lyophilized for later use. The preparation method of the methacrylamide gelatin / methacrylamide sodium alginate / hydroxyapatite composite hydrogel particles (Gel / Alg / HAP) includes the following steps: Dissolve gelatin and sodium alginate in their respective deionized water solutions, stirring thoroughly until dissolved. Then, the calcium chloride and disodium hydrogen phosphate solution was slowly added dropwise to the sodium alginate solution, the pH was adjusted to 8-10, and the mixture was stirred thoroughly overnight. The concentration of the calcium chloride and disodium hydrogen phosphate solution was 0.1wt% to 5wt%. Mix gelatin with a sodium alginate solution containing calcium chloride and disodium hydrogen phosphate, add methacrylamide MA dropwise, stir thoroughly and adjust the pH to 8-10; The reaction was carried out at 50°C for 3 hours. Finally, a large volume of deionized water was added to terminate the reaction. The mixture was then dialyzed for one week and lyophilized for later use.
2. The composite bio-ink according to claim 1, characterized in that, The bio-ink further includes bone marrow mesenchymal stem cells, a photoinitiator, and a light absorber.
3. The composite bio-ink according to claim 2, characterized in that, The concentration of the bone marrow mesenchymal stem cells was 5 x 10⁻⁶. 5 ~5x10 6 cells / mL; the photoinitiator is lithium phenyl (2,4,6-trimethylbenzoyl)phosphate, and the concentration of the photoinitiator is 0.05-0.5 wt%; the light absorber is EFL-UVAW-001, and the concentration of the light absorber is 0.01-0.1 wt%.
4. A composite biological scaffold, characterized in that, The scaffold is prepared by 3D printing using the composite bio-ink described in any one of claims 1 to 3.
5. A method for preparing the composite biological scaffold according to claim 4, characterized in that, Includes the following steps: S1. Create a 3D model using 3D Studio Max software; S2. Place the bio-ink according to any one of claims 1 to 3 into the ink tank, set the printing parameters, and print; S3. After printing, quickly place the printed cell scaffold into the culture medium.
6. The method for preparing the composite biological scaffold according to claim 5, characterized in that, The printing parameters mentioned in step S2 are: light intensity set to 5-20 mW / cm². -2 The exposure time is set to 8–20 seconds, the base layer is 2–5 layers, the bottom layer exposure time is set to 10–22 seconds, the layer height is set to 20–100 micrometers, and the printing temperature is 26–37℃.
Citation Information
Patent Citations
Projection type photocuring biological 3D printing method
CN116330644A
